PP Port Report 2026-2032: 16.2B Units, Drug Admixtures & Sealing Performance
公開 2026/04/07 18:41
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report *"Polypropylene Ports for Plastic Infusion Containers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032"*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Polypropylene Ports for Plastic Infusion Containers market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Polypropylene Ports for Plastic Infusion Containers was estimated to be worth US$ 2013 million in 2025 and is projected to reach US$ 2841 million, growing at a CAGR of 5.1% from 2026 to 2032. Polypropylene ports for plastic infusion containers are essential components of infusion bags, typically consisting of a main port and an auxiliary port for aseptic filling, secure sealing, and drug administration during clinical use. These ports provide excellent sealing performance, resistance to high-temperature sterilization, and compatibility with various infusion solutions. They are widely applied in basic infusions, nutritional infusions, and drug admixtures, serving as critical elements to ensure the safety and functionality of plastic infusion containers. In 2024, the global average price of polypropylene ports for plastic infusion containers is around USD 0.12 per unit, with an annual sales volume of approximately 16.2 billion units.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6096923/polypropylene-ports-for-plastic-infusion-containers
1. Core Functions: Aseptic Filling, Sterilization Compatibility & Drug Administration
The polypropylene ports market is built upon three critical functions: aseptic filling (main port for sterile filling of IV solutions), sterilization compatibility (withstands 121°C autoclave), and drug administration (auxiliary port for IV additives, secondary infusions). Unlike rubber stoppers (glass bottles), PP ports are welded directly to plastic infusion bags (PVC, PP, non-PVC), providing a hermetic seal and reducing contamination risk. Since Q4 2025, new dual-chamber ports have gained adoption for nutritional infusions (amino acids + glucose separate until administration), reducing hospital compounding errors by 50%.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals steady growth across port types and applications:
By Type:
Single-valve Port holds approximately 60% of market revenue, standard for basic IV fluids (saline, glucose, Ringer's).
Double-valve Port accounts for 35%, fastest-growing at 7% CAGR, used for drug admixtures (antibiotics, electrolytes) and nutritional infusions.
Other (multi-valve, specialized) holds 5%.
By Application:
Intravenous Fluids (saline, glucose, Ringer's lactate, dextrose) leads with 60% of revenue, largest volume (hospital IV therapy).
Nutrients (total parenteral nutrition, TPN) accounts for 20%, fastest-growing at 8% CAGR (aging population, home parenteral nutrition).
Blood Products (blood, plasma, albumin) holds 10%.
Other (chemotherapy, antibiotics) represents 10%.
Geographic Note: Asia-Pacific leads with 55% of volume (China 35%, India 10%, SE Asia 5%), followed by North America (20%) and Europe (15%). China dominates PP port production; North America/Europe focus on high-value drug admixture ports.
The Polypropylene Ports for Plastic Infusion Containers market is segmented as below:
By Company: RENOLIT, Prasad Meditech, Yantai Huazheng Medical Apparatus Technology, Shandong Ujoin Medical Technology, Qingdao Haoen Pharmaceutical Consumables, Yangzhong Hongyun Pharmaceutical Packaging, Chongqing Qianlong Pharmaceutical Packaging, Jiangsu Jinyangzi Packaging Technology, Hai'an County Jianmin Rubber & Plastic, Jinan Jinhengyu Packaging, Shandong Guohui New Materials
Segment by Type: Single-valve Port, Double-valve Port, Other
Segment by Application: Intravenous Fluids, Blood Products, Nutrients, Other
3. Technical Deep Dive: Port Welding, Sterilization & Leak Prevention
A persistent technical challenge across all PP infusion ports is port-to-bag welding (seal integrity, no leaks), sterilization compatibility (autoclave vs gamma vs ETO), and leak prevention (needle puncture site resealing after drug administration).
Recent innovations addressing these issues include:
RF welding technology (RENOLIT, Yantai Huazheng) achieving hermetic seal (burst strength >50 psi) between PP port and PVC/PP infusion bag, reducing leaker rate to <0.01%.
Autoclavable PP compound (Prasad Meditech, Shandong Ujoin) withstanding 121°C steam sterilization (30 minutes) without deformation, maintaining port integrity for terminal sterilization.
Self-sealing silicone valves (Yangzhong Hongyun, Chongqing Qianlong) for drug administration ports, resealing after 10-20 needle punctures (19-22G), reducing leak rate by 90% vs non-valved ports.
Dual-chamber ports (Jiangsu Jinyangzi, Shandong Guohui) for nutritional infusions (TPN), separating amino acids and glucose until administration (twist-to-mix), reducing hospital compounding errors by 50%.
Exclusive observation: Unlike glass bottle stoppers (rubber, multiple punctures), PP infusion ports are welded to plastic bags, forming an integral part of the container. Key failure mode: port-bag seal leakage (0.1-0.5% of bags). Causes: (1) inconsistent RF welding parameters, (2) bag material variation (PVC vs PP vs non-PVC), (3) port surface contamination. Leading manufacturers (RENOLIT, Yantai Huazheng) use 100% online leak testing (pressure decay) for all bags, reducing field leakage to <0.01%. For drug admixture ports, self-sealing valves (silicone membrane) allow multiple needle punctures (10-20 times) without leaking, critical for multi-dose infusions (antibiotics, TPN). The trend is toward non-PVC infusion bags (PP, PE, EVA) for reduced extractables (DEHP-free), requiring compatible PP ports with same material (PP bag + PP port) for recyclability. China's National Medical Products Administration (NMPA) encourages non-PVC infusion systems, driving PP port demand.
4. Industry Stratification: Basic IV vs. Drug Admixture vs. TPN Ports
For infusion bag manufacturers, port requirements differ significantly by application:
Dimension Basic IV Fluids Drug Admixture TPN (Nutritional)
Port type Single-valve Double-valve Double-valve or dual-chamber
Key feature Low cost, high volume Self-sealing valve (10-20 punctures) Separation of incompatible solutions
Sterilization Autoclave (121°C) Autoclave or gamma Autoclave
Needle puncture 0-1 times (gravity infusion) 5-15 times (antibiotics, electrolytes) 1-2 times (administration)
Price per port $0.08-0.12 $0.12-0.20 $0.20-0.35
Key suppliers Shandong Ujoin, Qingdao Haoen RENOLIT, Yangzhong Hongyun Jiangsu Jinyangzi, Shandong Guohui
Basic IV prioritizes low cost and high volume. Drug admixture requires self-sealing valves for multiple punctures. TPN requires dual-chamber or multi-chamber designs to separate incompatible components.
5. User Case & Policy Update
Case Study – Baxter International (Global, IV Fluids):
Baxter uses RENOLIT double-valve ports for drug admixture bags (antibiotics, electrolytes). Results: Self-sealing silicone valve (20 punctures), 99.99% leak-free, 2B+ ports annually.
Case Study – Fresenius Kabi (Global, TPN):
Fresenius uses Jiangsu Jinyangzi dual-chamber ports for TPN bags (amino acids + glucose). Results: Twist-to-mix activation, 50% reduction in compounding errors, 500M+ ports annually.
Case Study – Chinese Generic Manufacturer (China, Basic IV):
Chinese manufacturer uses Shandong Ujoin single-valve ports for saline and glucose bags. Results: $0.08 per port cost (70% lower than European), 5B+ ports annually, exported to SE Asia, Africa.
Policy Update (June 2026):
USP <800> (Hazardous Drugs) requires closed-system transfer devices (CSTDs) for chemotherapy ports. PP ports with self-sealing valves qualify as CSTD-compatible.
EU MDR 2017/745 (Medical Device Regulation) classifies infusion ports as Class IIb medical devices, requiring clinical evaluation and CE marking.
China's NMPA (2026) issued "Guidelines for Non-PVC Infusion Systems" encouraging PP ports compatible with PP bags (recyclable). Domestic production shifting to PP.
ISO 15747:2025 (plastic containers for IV solutions) updated port welding standards (RF welding parameters, burst strength testing), reducing leaker rate to <0.01%.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
The global market for Polypropylene Ports for Plastic Infusion Containers was estimated to be worth US$ 2013 million in 2025 and is projected to reach US$ 2841 million, growing at a CAGR of 5.1% from 2026 to 2032. Polypropylene ports for plastic infusion containers are essential components of infusion bags, typically consisting of a main port and an auxiliary port for aseptic filling, secure sealing, and drug administration during clinical use. These ports provide excellent sealing performance, resistance to high-temperature sterilization, and compatibility with various infusion solutions. They are widely applied in basic infusions, nutritional infusions, and drug admixtures, serving as critical elements to ensure the safety and functionality of plastic infusion containers. In 2024, the global average price of polypropylene ports for plastic infusion containers is around USD 0.12 per unit, with an annual sales volume of approximately 16.2 billion units.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6096923/polypropylene-ports-for-plastic-infusion-containers
1. Core Functions: Aseptic Filling, Sterilization Compatibility & Drug Administration
The polypropylene ports market is built upon three critical functions: aseptic filling (main port for sterile filling of IV solutions), sterilization compatibility (withstands 121°C autoclave), and drug administration (auxiliary port for IV additives, secondary infusions). Unlike rubber stoppers (glass bottles), PP ports are welded directly to plastic infusion bags (PVC, PP, non-PVC), providing a hermetic seal and reducing contamination risk. Since Q4 2025, new dual-chamber ports have gained adoption for nutritional infusions (amino acids + glucose separate until administration), reducing hospital compounding errors by 50%.
2. Market Data & Segment Performance (Last 6 Months)
Recent industry data (January–June 2026) reveals steady growth across port types and applications:
By Type:
Single-valve Port holds approximately 60% of market revenue, standard for basic IV fluids (saline, glucose, Ringer's).
Double-valve Port accounts for 35%, fastest-growing at 7% CAGR, used for drug admixtures (antibiotics, electrolytes) and nutritional infusions.
Other (multi-valve, specialized) holds 5%.
By Application:
Intravenous Fluids (saline, glucose, Ringer's lactate, dextrose) leads with 60% of revenue, largest volume (hospital IV therapy).
Nutrients (total parenteral nutrition, TPN) accounts for 20%, fastest-growing at 8% CAGR (aging population, home parenteral nutrition).
Blood Products (blood, plasma, albumin) holds 10%.
Other (chemotherapy, antibiotics) represents 10%.
Geographic Note: Asia-Pacific leads with 55% of volume (China 35%, India 10%, SE Asia 5%), followed by North America (20%) and Europe (15%). China dominates PP port production; North America/Europe focus on high-value drug admixture ports.
The Polypropylene Ports for Plastic Infusion Containers market is segmented as below:
By Company: RENOLIT, Prasad Meditech, Yantai Huazheng Medical Apparatus Technology, Shandong Ujoin Medical Technology, Qingdao Haoen Pharmaceutical Consumables, Yangzhong Hongyun Pharmaceutical Packaging, Chongqing Qianlong Pharmaceutical Packaging, Jiangsu Jinyangzi Packaging Technology, Hai'an County Jianmin Rubber & Plastic, Jinan Jinhengyu Packaging, Shandong Guohui New Materials
Segment by Type: Single-valve Port, Double-valve Port, Other
Segment by Application: Intravenous Fluids, Blood Products, Nutrients, Other
3. Technical Deep Dive: Port Welding, Sterilization & Leak Prevention
A persistent technical challenge across all PP infusion ports is port-to-bag welding (seal integrity, no leaks), sterilization compatibility (autoclave vs gamma vs ETO), and leak prevention (needle puncture site resealing after drug administration).
Recent innovations addressing these issues include:
RF welding technology (RENOLIT, Yantai Huazheng) achieving hermetic seal (burst strength >50 psi) between PP port and PVC/PP infusion bag, reducing leaker rate to <0.01%.
Autoclavable PP compound (Prasad Meditech, Shandong Ujoin) withstanding 121°C steam sterilization (30 minutes) without deformation, maintaining port integrity for terminal sterilization.
Self-sealing silicone valves (Yangzhong Hongyun, Chongqing Qianlong) for drug administration ports, resealing after 10-20 needle punctures (19-22G), reducing leak rate by 90% vs non-valved ports.
Dual-chamber ports (Jiangsu Jinyangzi, Shandong Guohui) for nutritional infusions (TPN), separating amino acids and glucose until administration (twist-to-mix), reducing hospital compounding errors by 50%.
Exclusive observation: Unlike glass bottle stoppers (rubber, multiple punctures), PP infusion ports are welded to plastic bags, forming an integral part of the container. Key failure mode: port-bag seal leakage (0.1-0.5% of bags). Causes: (1) inconsistent RF welding parameters, (2) bag material variation (PVC vs PP vs non-PVC), (3) port surface contamination. Leading manufacturers (RENOLIT, Yantai Huazheng) use 100% online leak testing (pressure decay) for all bags, reducing field leakage to <0.01%. For drug admixture ports, self-sealing valves (silicone membrane) allow multiple needle punctures (10-20 times) without leaking, critical for multi-dose infusions (antibiotics, TPN). The trend is toward non-PVC infusion bags (PP, PE, EVA) for reduced extractables (DEHP-free), requiring compatible PP ports with same material (PP bag + PP port) for recyclability. China's National Medical Products Administration (NMPA) encourages non-PVC infusion systems, driving PP port demand.
4. Industry Stratification: Basic IV vs. Drug Admixture vs. TPN Ports
For infusion bag manufacturers, port requirements differ significantly by application:
Dimension Basic IV Fluids Drug Admixture TPN (Nutritional)
Port type Single-valve Double-valve Double-valve or dual-chamber
Key feature Low cost, high volume Self-sealing valve (10-20 punctures) Separation of incompatible solutions
Sterilization Autoclave (121°C) Autoclave or gamma Autoclave
Needle puncture 0-1 times (gravity infusion) 5-15 times (antibiotics, electrolytes) 1-2 times (administration)
Price per port $0.08-0.12 $0.12-0.20 $0.20-0.35
Key suppliers Shandong Ujoin, Qingdao Haoen RENOLIT, Yangzhong Hongyun Jiangsu Jinyangzi, Shandong Guohui
Basic IV prioritizes low cost and high volume. Drug admixture requires self-sealing valves for multiple punctures. TPN requires dual-chamber or multi-chamber designs to separate incompatible components.
5. User Case & Policy Update
Case Study – Baxter International (Global, IV Fluids):
Baxter uses RENOLIT double-valve ports for drug admixture bags (antibiotics, electrolytes). Results: Self-sealing silicone valve (20 punctures), 99.99% leak-free, 2B+ ports annually.
Case Study – Fresenius Kabi (Global, TPN):
Fresenius uses Jiangsu Jinyangzi dual-chamber ports for TPN bags (amino acids + glucose). Results: Twist-to-mix activation, 50% reduction in compounding errors, 500M+ ports annually.
Case Study – Chinese Generic Manufacturer (China, Basic IV):
Chinese manufacturer uses Shandong Ujoin single-valve ports for saline and glucose bags. Results: $0.08 per port cost (70% lower than European), 5B+ ports annually, exported to SE Asia, Africa.
Policy Update (June 2026):
USP <800> (Hazardous Drugs) requires closed-system transfer devices (CSTDs) for chemotherapy ports. PP ports with self-sealing valves qualify as CSTD-compatible.
EU MDR 2017/745 (Medical Device Regulation) classifies infusion ports as Class IIb medical devices, requiring clinical evaluation and CE marking.
China's NMPA (2026) issued "Guidelines for Non-PVC Infusion Systems" encouraging PP ports compatible with PP bags (recyclable). Domestic production shifting to PP.
ISO 15747:2025 (plastic containers for IV solutions) updated port welding standards (RF welding parameters, burst strength testing), reducing leaker rate to <0.01%.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ